甲型流感病毒,H5N1 亚型的临床试验
总计5024个结果
-
University Health Network, TorontoHoffmann-La Roche终止
-
Universitas PadjadjaranUniversiti Sains Malaysia; Biofarma完全的
-
University of Alabama at BirminghamCentre for Infectious Disease Research in Zambia; Tropical Gastroenterology and Nutrition Group主动,不招人
-
Third Affiliated Hospital, Sun Yat-Sen University招聘中
-
National Institute of Diabetes and Digestive and...完全的
-
Bristol-Myers Squibb完全的
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)完全的
-
AbbVie完全的
-
AbbVie完全的丙型肝炎病毒感染 | 慢性丙型肝炎 | 人类免疫缺陷病毒感染 | 代偿性肝硬化和非肝硬化
-
AbbVie完全的
-
Biocad完全的肝炎 | 丙型肝炎 | 丙型肝炎/人类免疫缺陷病毒合并感染俄罗斯联邦
-
Kazakh Association of Internal Medicine Specialists尚未招聘
-
The University of Hong KongResearch Grant Council招聘中
-
Gilead Sciences完全的
-
GlaxoSmithKline完全的
-
Institut de Médecine et d'Epidémiologie Appliquée...Gilead Sciences; Roche Pharma AG; ANRS, Emerging Infectious Diseases; BioMérieux; Mairie de Paris完全的
-
ANRS, Emerging Infectious DiseasesMCM Vaccines B.V.完全的
-
Taipei Veterans General Hospital, TaiwanBristol-Myers Squibb完全的
-
Valme University HospitalHospital Universitario Virgen Macarena; Hospital Universitario Reina Sofia de Cordoba; Hospital... 和其他合作者完全的
-
National Institute of Allergy and Infectious Diseases...撤销
-
MCM Vaccines B.V.Merck Sharp & Dohme LLC; Sanofi Pasteur, a Sanofi Company完全的
-
University Paris 7 - Denis Diderot未知
-
AbbVie完全的慢性丙型肝炎 | 丙型肝炎病毒 | 丙型肝炎病毒 | 直接作用抗病毒剂(DAA)-经验丰富
-
Kirby InstituteMerck Sharp & Dohme LLC; The University of New South Wales完全的
-
National Cancer Institute (NCI)Inovio Pharmaceuticals主动,不招人
-
Merck Sharp & Dohme LLC完全的
-
Oregon Health and Science University完全的
-
University of Texas Southwestern Medical CenterGlaxoSmithKline终止